Management Team

Adam Christie (Board member, Executive Chairman)
Adam has a strong background in marketing, business strategy and also research and development garnered throughout his distinguished career. Prior to joinging the LUX board he was Chief Business Officer at PowderMed where he led business development and commercial stategy which culminated in the successful sale of the company to Pfizer in late 2006. His early career included positions at GlaxoSmithKline, ABN Amro, Fisons, Abbott Laboratories and Schering AG, alongside an educational background including a BSc (Hons) in Pharmacology/Physiology at Southampton University and a subsequent MBA with distinction at Warwick University.

Emma Perfect (Board member, Managing Director and Chief Scientific Officer)
Emma graduated from the University of Oxford with a first class honours degree in Biological Sciences. She has since completed a DPhil in Plant Disease. Emma joined LUX in 2003 and manages a team of highly skilled scientists and she heads up LUX research programmes. During her time with LUX Emma has developed a comprehensive intellectual property strategy to feed into the LUX business model of building the technology portfolio. Emma has extensive experience in assessing new technology opportunities and has been instrumental in bringing new technology into LUX building up the company's core skills.  
 
Jenny Young (Chief Operating Officer)
Jenny has worked in the Life Sciences and Pharmaceutical sectors since 2000.  She joined the company from Advocates Ltd., a pharmaceutical consultancy, where her role involved project management, regulatory and technical consultancy in the area of pharmaceutical manufacturing.  She previously gained skills in sales and business development when she helped found the technology company Nyrion Ltd.  Prior to this Jenny worked as a Project Manager at ExpressOn BioSystems Ltd, a small biotechnology company.  Jenny holds a first class honours degree awarded by the University of Oxford.